Showing results (2961-2970 of 4,130) with videos related to
Sort By:
Pageof 413
Human Gene Therapy|February 24, 1998
A double-blind, placebo controlled, dose ranging study to evaluate the safety and biological efficacy of the lipid-DNA complex GR213487B in the nasal epithelium of adult patients with cystic fibrosisM R Knowles, P G Noone, K Hohneker, et al.Human Gene Therapy|June 2, 1998
Dose-dependent doxycycline-mediated adrenocorticotropic hormone secretion from encapsulated Tet-on proopiomelanocortin Neuro2A cells in the subarachnoid spaceY Saitoh, Y Eguchi, Y Hagihara, et al.Human Gene Therapy|June 2, 1998
Enhanced green fluorescent protein as an efficient reporter gene for retroviral transduction of human multipotent lymphoid precursorsA R Ramiro, V G De Yébenes, C Trigueros, et al.Human Gene Therapy|June 13, 1998
Gene therapy strategies for treating Epstein-Barr virus-associated lymphomas: comparison of two different Epstein-Barr virus-based vectorsS Kenney, J Q Ge, E M Westphal, et al.Human Gene Therapy|June 13, 1998
A method of limited replication for the efficient in vivo delivery of adenovirus to cancer cellsJ S Han, D Qian, M S Wicha, et al.Human Gene Therapy|June 13, 1998
Adenovirus-mediated in vivo gene transfer in guinea pig middle ear mucosaM Mondain, S Restituito, V Vincenti, et al.Human Gene Therapy|April 29, 1998
In vitro selection for K562 cells with higher retrovirally mediated copy number of aldehyde dehydrogenase class-1 and higher resistance to 4-hydroperoxycyclophosphamideJ S Moreb, M Schweder, B Gray, et al.Human Gene Therapy|April 29, 1998
High-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscle of dystrophic dogs: prolongation of expression with immunosuppressionJ M Howell, H Lochmüller, A O'Hara, et al.Human Gene Therapy|April 29, 1998
Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airwaysY Zhang, Q Jiang, L Dudus, et al.Human Gene Therapy|April 29, 1998
Combination therapy with interleukin-2 and wild-type p53 expressed by adenoviral vectors potentiates tumor regression in a murine model of breast cancerB M Pützer, J L Bramson, C L Addison, et al.Pageof 413